25-hydroxyvitamin D and Endometriosis: A bidirectional Mendelian randomization study.
25-hydroxyvitamin D
Causal relationship
Endometriosis
Endometriosis of ovary
Mendelian randomization
Journal
Reproductive sciences (Thousand Oaks, Calif.)
ISSN: 1933-7205
Titre abrégé: Reprod Sci
Pays: United States
ID NLM: 101291249
Informations de publication
Date de publication:
21 Mar 2024
21 Mar 2024
Historique:
received:
02
11
2023
accepted:
11
03
2024
medline:
21
3
2024
pubmed:
21
3
2024
entrez:
21
3
2024
Statut:
aheadofprint
Résumé
Numerous studies have demonstrated a correlation between serum 25-hydroxyvitamin D (25OHD) and endometriosis. However, the precise nature of this association remains elusive. The causal connection between 25OHD and endometriosis remains uncertain, as it is yet to be determined whether one directly influences the other. The objective of our research was to investigate the cause-and-effect connection between 25OHD and endometriosis. The study employed Mendelian randomization (MR) in a bidirectional two-sample investigation to examine the causal relationship between 25OHD and endometriosis. The analysis utilized the most recent publicly accessible statistics from the genome-wide association study (GWAS) encompassing 25OHD, endometriosis, and its five subtypes. The primary analytical approach employed was Inverse-Variance Weighting (IVW), accompanied by supplementary analysis methods including weighted median, MR-Egger, simple mode, and weighted mode. Furthermore, sensitivity analyses were conducted to assess the potential influence of heterogeneity and pleiotropy on the MR outcomes. MR primary analysis showed no significant causal effect of 25OHD on endometriosis (OR = 0.892, 95%CI = 0.745 ~ 1.068, P = 0.213). Similarly, there was no evidence to support a causal relationship of endometriosis on 25OHD (IVW Beta = 0.005, 95%CI = 0.993 ~ 1.018, P = 0.406). However, when conducting MR analysis on different subtypes of endometriosis and 25OHD, we found a positive correlation between endometriosis of ovary and 25OHD level (IVW Beta = 0.012, 95%CI = 1.002 ~ 1.022, P = 0.024). This study indicates that there is no causal relationship between serum 25OHD and endometriosis. However, it is important to note that serum 25OHD levels will increase in patients with endometriosis of the ovary. Further observational studies and clinical trials are indispensable.
Identifiants
pubmed: 38512698
doi: 10.1007/s43032-024-01517-8
pii: 10.1007/s43032-024-01517-8
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Society for Reproductive Investigation.
Références
Vazgiourakis VM, Zervou MI, Papageorgiou L, et al. Association of endometriosis with cardiovascular disease: Genetic aspects (Review). Int J Mol Med. 2023;51(3):29. https://doi.org/10.3892/ijmm.2023.5232 .
doi: 10.3892/ijmm.2023.5232
pubmed: 36799179
pmcid: 9943539
Rowlands IJ, Abbott JA, Montgomery GW, et al. Prevalence and incidence of endometriosis in Australian women: a data linkage cohort study. BJOG. 2021;128(4):657–65. https://doi.org/10.1111/1471-0528.16447 .
doi: 10.1111/1471-0528.16447
pubmed: 32757329
McGrath IM, Montgomery GW, Mortlock S. Insights from Mendelian randomization and genetic correlation analyses into the relationship between endometriosis and its comorbidities. Hum Reprod Update. 2023;29(5):655–74. https://doi.org/10.1093/humupd/dmad009 .
doi: 10.1093/humupd/dmad009
pubmed: 37159502
pmcid: 10477944
Fawole AO, Bello FA, Ogunbode O, et al. Endometriosis and associated symptoms among Nigerian women. Int J Gynaecol Obstet. 2015;130(2):190–4. https://doi.org/10.1016/j.ijgo.2015.02.030 .
doi: 10.1016/j.ijgo.2015.02.030
pubmed: 25935474
Lamceva J, Uljanovs R, Strumfa I. The main theories on the pathogenesis of endometriosis. Int J Mol Sci. 2023;24(5):4254. https://doi.org/10.3390/ijms24054254 .
doi: 10.3390/ijms24054254
pubmed: 36901685
pmcid: 10001466
Norman PE, Powell JT. Vitamin D and cardiovascular disease. Circ Res. 2014;114(2):379–93. https://doi.org/10.1161/CIRCRESAHA.113.301241 .
doi: 10.1161/CIRCRESAHA.113.301241
pubmed: 24436433
Jiang X, O'Reilly PF, Aschard H, et al. Genome-wide association study in 79,366 European-ancestry individuals informs the genetic architecture of 25-hydroxyvitamin D levels. Nat Commun. 2018;9(1):260 https://doi.org/10.1038/s41467-017-02662-2
Somigliana E, Panina-Bordignon P, Murone S, et al. Vitamin D reserve is higher in women with endometriosis. Hum Reprod. 2007;22(8):2273–8. https://doi.org/10.1093/humrep/dem142 .
doi: 10.1093/humrep/dem142
pubmed: 17548365
Harris HR, Chavarro JE, Malspeis S, et al. Dairy-food, calcium, magnesium, and vitamin D intake and endometriosis: a prospective cohort study. Am J Epidemiol. 2013;177(5):420–30. https://doi.org/10.1093/aje/kws247 .
doi: 10.1093/aje/kws247
pubmed: 23380045
pmcid: 3626048
Kalaitzopoulos DR, Samartzis N, Daniilidis A, et al. Effects of vitamin D supplementation in endometriosis: a systematic review. Reprod Biol Endocrinol. 2022;20(1):176. https://doi.org/10.1186/s12958-022-01051-9 .
doi: 10.1186/s12958-022-01051-9
pubmed: 36578019
pmcid: 9795583
Kalaitzopoulos DR, Lempesis IG, Athanasaki F, et al. Association between vitamin D and endometriosis: a systematic review. Hormones (Athens). 2020;19(2):109–21. https://doi.org/10.1007/s42000-019-00166-w .
doi: 10.1007/s42000-019-00166-w
pubmed: 31863346
Giampaolino PC, Foreste LD, et al. Is there a Relationship between Vitamin D and Endometriosis? An Overview of the Literature. Curr Pharma Des. 2019;25:22. https://doi.org/10.2174/1381612825666190722095401 .
doi: 10.2174/1381612825666190722095401
Sayegh L, Gel-H F, Nassar AH. Vitamin D in endometriosis: a causative or confounding factor? Metabolism. 2014;63(1):32–41. https://doi.org/10.1016/j.metabolism.2013.09.012 .
doi: 10.1016/j.metabolism.2013.09.012
pubmed: 24135500
Davies NM, Holmes MV, Davey SG. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ. 2018;362:601. https://doi.org/10.1136/bmj.k601 .
doi: 10.1136/bmj.k601
Skrivankova VW, Richmond RC, Woolf BAR, et al. Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization: The STROBE-MR Statement. JAMA. 2021;326(16):1614–21. https://doi.org/10.1001/jama.2021.18236 .
doi: 10.1001/jama.2021.18236
pubmed: 34698778
Lawlor DA, Harbord RM, Sterne JA, et al. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med. 2008;27(8):1133–63. https://doi.org/10.1002/sim.3034 .
doi: 10.1002/sim.3034
pubmed: 17886233
Gupta V, Walia GK, Sachdeva MP. “Mendelian randomization”: an approach for exploring causal relations in epidemiology. Public Health. 2017;145:113–9. https://doi.org/10.1016/j.puhe.2016.12.033 .
doi: 10.1016/j.puhe.2016.12.033
pubmed: 28359378
Revez JA, Lin T, Qiao Z, et al. Genome-wide association study identifies 143 loci associated with 25 hydroxyvitamin D concentration. Nat Commun. 2020;11(1):1647. https://doi.org/10.1038/s41467-020-15421-7 .
doi: 10.1038/s41467-020-15421-7
pubmed: 32242144
pmcid: 7118120
Hemani G, Zheng J, Elsworth B, et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife. 2018;7:e34408. https://doi.org/10.7554/eLife.34408 .
doi: 10.7554/eLife.34408
pubmed: 29846171
pmcid: 5976434
Kamat MA, Blackshaw JA, Young R, et al. PhenoScanner V2: an expanded tool for searching human genotype-phenotype associations. Bioinformatics. 2019;35(22):4851–3. https://doi.org/10.1093/bioinformatics/btz469 .
doi: 10.1093/bioinformatics/btz469
pubmed: 31233103
pmcid: 6853652
Chen L, Yang H, Li H, et al. Insights into modifiable risk factors of cholelithiasis: A Mendelian randomization study. Hepatology. 2022;75(4):785–96. https://doi.org/10.1002/hep.32183 .
doi: 10.1002/hep.32183
pubmed: 34624136
Bowden J, Del Greco MF, Minelli C, et al. Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic. Int J Epidemiol. 2016;45(6):1961–74. https://doi.org/10.1093/ije/dyw220 .
doi: 10.1093/ije/dyw220
pubmed: 27616674
pmcid: 5446088
Verbanck M, Chen CY, Neale B, et al. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50(5):693–8. https://doi.org/10.1038/s41588-018-0099-7 .
doi: 10.1038/s41588-018-0099-7
pubmed: 29686387
pmcid: 6083837
Gage SH, Jones HJ, Burgess S, et al. Assessing causality in associations between cannabis use and schizophrenia risk: a two-sample Mendelian randomization study. Psychol Med. 2017;47(5):971–80. https://doi.org/10.1017/S0033291716003172 .
doi: 10.1017/S0033291716003172
pubmed: 27928975
Delbandi AA, Torab M, Abdollahi E, et al. Vitamin D deficiency as a risk factor for endometriosis in Iranian women. J Reprod Immunol. 2021;143:103266. https://doi.org/10.1016/j.jri.2020.103266 .
doi: 10.1016/j.jri.2020.103266
pubmed: 33385732
Qiu Y, Yuan S, Wang H. Vitamin D status in endometriosis: a systematic review and meta-analysis. Arch Gynecol Obstet. 2020;302(1):141–52. https://doi.org/10.1007/s00404-020-05576-5 .
doi: 10.1007/s00404-020-05576-5
pubmed: 32430755
Ciavattini A, Serri M, DelliCarpini G, et al. Ovarian endometriosis and vitamin D serum levels. Gynecol Endocrinol. 2017;33(2):164–7. https://doi.org/10.1080/09513590.2016.1239254 .
doi: 10.1080/09513590.2016.1239254
pubmed: 27809683
Buggio L, Somigliana E, Pizzi MN, et al. 25-Hydroxyvitamin D Serum Levels and Endometriosis: Results of a Case-Control Study. Reprod Sci. 2019;26(2):172–7. https://doi.org/10.1177/1933719118766259 .
doi: 10.1177/1933719118766259
pubmed: 29587615
Hartwell D, Rødbro P, Jensen SB, Thomsen K, Christiansen C. Vitamin D metabolites–relation to age, menopause and endometriosis. Scand J Clin Lab Invest. 1990;50(2):115–21. https://doi.org/10.3109/00365519009089142 .
doi: 10.3109/00365519009089142
pubmed: 2339276
Agic A, Xu H, Altgassen C, et al. Relative expression of 1,25-dihydroxyvitamin D3 receptor, vitamin D 1 alpha-hydroxylase, vitamin D 24-hydroxylase, and vitamin D 25-hydroxylase in endometriosis and gynecologic cancers. Reprod Sci. 2007;14(5):486–97. https://doi.org/10.1177/1933719107304565 .
doi: 10.1177/1933719107304565
pubmed: 17913968
Jeon SM, Shin EA. Exploring vitamin D metabolism and function in cancer. Exp Mol Med. 2018;50(4):1–14. https://doi.org/10.1038/s12276-018-0038-9 .
doi: 10.1038/s12276-018-0038-9
pubmed: 30333528
Li Wang, Xiaofeng Yang. Study on the relationship between vitamin d and endometriosis. Chin J Woman Child Health Res. 2019;08:908–12.
Faserl K, Golderer G, Kremser L, et al. Polymorphism in vitamin D-binding protein as a genetic risk factor in the pathogenesis of endometriosis. J Clin Endocrinol Metab. 2011;96(1):E233–41. https://doi.org/10.1210/jc.2010-1532 .
doi: 10.1210/jc.2010-1532
pubmed: 20980430
Hapangama DK, Raju RS, Valentijn AJ, et al. Aberrant expression of metastasis-inducing proteins in ectopic and matched eutopic endometrium of women with endometriosis: implications for the pathogenesis of endometriosis. Hum Reprod. 2012;27(2):394–407. https://doi.org/10.1093/humrep/der412 .
doi: 10.1093/humrep/der412
pubmed: 22147918
Mariani M, Viganò P, Gentilini D, et al. The selective vitamin D receptor agonist, elocalcitol, reduces endometriosis development in a mouse model by inhibiting peritoneal inflammation. Hum Reprod. 2012;27(7):2010–9. https://doi.org/10.1093/humrep/des150 .
doi: 10.1093/humrep/des150
pubmed: 22588001
Londero AP, Calcagno A, Grassi T, et al. Survivin, MMP-2, MT1-MMP, and TIMP-2: their impact on survival, implantation, and proliferation of endometriotic tissues. Virchows Arch. 2012;461(5):589–99. https://doi.org/10.1007/s00428-012-1301-4 .
doi: 10.1007/s00428-012-1301-4
pubmed: 23011643
Yilmaz B, Sucak A, Kilic S, et al. Metformin regresses endometriotic implants in rats by improving implant levels of superoxide dismutase, vascular endothelial growth factor, tissue inhibitor of metalloproteinase-2, and matrix metalloproteinase-9. Am J Obstet Gynecol. 2010;202(4):368.e1-368.e3688. https://doi.org/10.1016/j.ajog.2009.10.873 .
doi: 10.1016/j.ajog.2009.10.873
pubmed: 20035912
Baeke F, Etten EV, Overbergh L, Mathieu C. Vitamin D3 and the immune system: maintaining the balance in health and disease. Nutr Res Rev. 2007;20(1):106–18. https://doi.org/10.1017/S0954422407742713 .
doi: 10.1017/S0954422407742713
pubmed: 19079863
Mathieu C, Adorini L. The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents. Trends Mol Med. 2002;8(4):174–9. https://doi.org/10.1016/s1471-4914(02)02294-3 .
doi: 10.1016/s1471-4914(02)02294-3
pubmed: 11927275
Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911–30. https://doi.org/10.1210/jc.2011-0385 .
doi: 10.1210/jc.2011-0385
pubmed: 21646368